Differential roles of telomere attrition in type I and II endometrial carcinogenesis

Esra A. Akbay, Cristina M. Contreras, Samanthi A. Perera, James P. Sullivan, Russell R. Broaddus, John O. Schorge, Raheela Ashfaq, Hossein Saboorian, Kwok Kin Wong, Diego H. Castrillon

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Endometrial cancer has been generally categorized into two broad groups of tumors, type I (TI) and type II (TII), with distinct epidemiological/clinical features and genetic alterations. Because telomere attrition appears to trigger genomic instability in certain cancers, we explored the role of telomere dysfunction in endometrial cancer by analyzing telomeres and other markers of telomere status in both tumor types. We describe a new method, telomere chromogenic in situ hybridization, which permitted us to detect cells with short telomeres relative to control (stromal) cells within the same tissue section. Using this method,we found that both types of tumor cells had short telomeres. However, only TII tumors were significantly associated with critical telomere shortening in adjacent, morphologically normal epithelium, suggesting that telomere shortening contributes to the initiation of TII but not TI tumors. To explore this hypothesis, we analyzed mice with critically short telomeres and documented distinctive endometrial lesions that histologically resembled the in situ precursor of TII serous carcinomas; these lesions have not been observed previously in TI mouse models of endometrial cancer. Based on this and previous studies, we propose a model in which telomere attrition contributes to the initiation of TII and progression of TI endometrial cancers.

Original languageEnglish (US)
Pages (from-to)536-544
Number of pages9
JournalAmerican Journal of Pathology
Volume173
Issue number2
DOIs
StatePublished - Aug 2008

Fingerprint

Telomere
Carcinogenesis
Endometrial Neoplasms
Telomere Shortening
Neoplasms
Genomic Instability
Stromal Cells
In Situ Hybridization
Epithelium
Carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Akbay, E. A., Contreras, C. M., Perera, S. A., Sullivan, J. P., Broaddus, R. R., Schorge, J. O., ... Castrillon, D. H. (2008). Differential roles of telomere attrition in type I and II endometrial carcinogenesis. American Journal of Pathology, 173(2), 536-544. https://doi.org/10.2353/ajpath.2008.071179

Differential roles of telomere attrition in type I and II endometrial carcinogenesis. / Akbay, Esra A.; Contreras, Cristina M.; Perera, Samanthi A.; Sullivan, James P.; Broaddus, Russell R.; Schorge, John O.; Ashfaq, Raheela; Saboorian, Hossein; Wong, Kwok Kin; Castrillon, Diego H.

In: American Journal of Pathology, Vol. 173, No. 2, 08.2008, p. 536-544.

Research output: Contribution to journalArticle

Akbay, EA, Contreras, CM, Perera, SA, Sullivan, JP, Broaddus, RR, Schorge, JO, Ashfaq, R, Saboorian, H, Wong, KK & Castrillon, DH 2008, 'Differential roles of telomere attrition in type I and II endometrial carcinogenesis', American Journal of Pathology, vol. 173, no. 2, pp. 536-544. https://doi.org/10.2353/ajpath.2008.071179
Akbay, Esra A. ; Contreras, Cristina M. ; Perera, Samanthi A. ; Sullivan, James P. ; Broaddus, Russell R. ; Schorge, John O. ; Ashfaq, Raheela ; Saboorian, Hossein ; Wong, Kwok Kin ; Castrillon, Diego H. / Differential roles of telomere attrition in type I and II endometrial carcinogenesis. In: American Journal of Pathology. 2008 ; Vol. 173, No. 2. pp. 536-544.
@article{f50db6a43f9a48818860f13238ed7525,
title = "Differential roles of telomere attrition in type I and II endometrial carcinogenesis",
abstract = "Endometrial cancer has been generally categorized into two broad groups of tumors, type I (TI) and type II (TII), with distinct epidemiological/clinical features and genetic alterations. Because telomere attrition appears to trigger genomic instability in certain cancers, we explored the role of telomere dysfunction in endometrial cancer by analyzing telomeres and other markers of telomere status in both tumor types. We describe a new method, telomere chromogenic in situ hybridization, which permitted us to detect cells with short telomeres relative to control (stromal) cells within the same tissue section. Using this method,we found that both types of tumor cells had short telomeres. However, only TII tumors were significantly associated with critical telomere shortening in adjacent, morphologically normal epithelium, suggesting that telomere shortening contributes to the initiation of TII but not TI tumors. To explore this hypothesis, we analyzed mice with critically short telomeres and documented distinctive endometrial lesions that histologically resembled the in situ precursor of TII serous carcinomas; these lesions have not been observed previously in TI mouse models of endometrial cancer. Based on this and previous studies, we propose a model in which telomere attrition contributes to the initiation of TII and progression of TI endometrial cancers.",
author = "Akbay, {Esra A.} and Contreras, {Cristina M.} and Perera, {Samanthi A.} and Sullivan, {James P.} and Broaddus, {Russell R.} and Schorge, {John O.} and Raheela Ashfaq and Hossein Saboorian and Wong, {Kwok Kin} and Castrillon, {Diego H.}",
year = "2008",
month = "8",
doi = "10.2353/ajpath.2008.071179",
language = "English (US)",
volume = "173",
pages = "536--544",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Differential roles of telomere attrition in type I and II endometrial carcinogenesis

AU - Akbay, Esra A.

AU - Contreras, Cristina M.

AU - Perera, Samanthi A.

AU - Sullivan, James P.

AU - Broaddus, Russell R.

AU - Schorge, John O.

AU - Ashfaq, Raheela

AU - Saboorian, Hossein

AU - Wong, Kwok Kin

AU - Castrillon, Diego H.

PY - 2008/8

Y1 - 2008/8

N2 - Endometrial cancer has been generally categorized into two broad groups of tumors, type I (TI) and type II (TII), with distinct epidemiological/clinical features and genetic alterations. Because telomere attrition appears to trigger genomic instability in certain cancers, we explored the role of telomere dysfunction in endometrial cancer by analyzing telomeres and other markers of telomere status in both tumor types. We describe a new method, telomere chromogenic in situ hybridization, which permitted us to detect cells with short telomeres relative to control (stromal) cells within the same tissue section. Using this method,we found that both types of tumor cells had short telomeres. However, only TII tumors were significantly associated with critical telomere shortening in adjacent, morphologically normal epithelium, suggesting that telomere shortening contributes to the initiation of TII but not TI tumors. To explore this hypothesis, we analyzed mice with critically short telomeres and documented distinctive endometrial lesions that histologically resembled the in situ precursor of TII serous carcinomas; these lesions have not been observed previously in TI mouse models of endometrial cancer. Based on this and previous studies, we propose a model in which telomere attrition contributes to the initiation of TII and progression of TI endometrial cancers.

AB - Endometrial cancer has been generally categorized into two broad groups of tumors, type I (TI) and type II (TII), with distinct epidemiological/clinical features and genetic alterations. Because telomere attrition appears to trigger genomic instability in certain cancers, we explored the role of telomere dysfunction in endometrial cancer by analyzing telomeres and other markers of telomere status in both tumor types. We describe a new method, telomere chromogenic in situ hybridization, which permitted us to detect cells with short telomeres relative to control (stromal) cells within the same tissue section. Using this method,we found that both types of tumor cells had short telomeres. However, only TII tumors were significantly associated with critical telomere shortening in adjacent, morphologically normal epithelium, suggesting that telomere shortening contributes to the initiation of TII but not TI tumors. To explore this hypothesis, we analyzed mice with critically short telomeres and documented distinctive endometrial lesions that histologically resembled the in situ precursor of TII serous carcinomas; these lesions have not been observed previously in TI mouse models of endometrial cancer. Based on this and previous studies, we propose a model in which telomere attrition contributes to the initiation of TII and progression of TI endometrial cancers.

UR - http://www.scopus.com/inward/record.url?scp=48749100496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749100496&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2008.071179

DO - 10.2353/ajpath.2008.071179

M3 - Article

C2 - 18599611

AN - SCOPUS:48749100496

VL - 173

SP - 536

EP - 544

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -